Two Major Pharma M&A Deals Yield Big-Firm Bonanza

Weil, Wachtell, Shearman, Simpson, Latham and Davis Polk all got the year's second quarter off to a strong start by grabbing roles on one of two big pharmaceutical deals announced Monday: Irish specialty drugmaker Mallinckrodt's $5.6 billion cash-and-stock purchase of California's Questcor Pharmaceuticals and India's Sun Pharmaceutical Industries' $3.2 billion buy of struggling rival Ranbaxy Laboratories.

Sign up for a free Law.com trial now!

Law.com's Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on Law.com
  • The free Law.com InPractice digital newsletter
  • Personalized legal news on the Law.com mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Law.com Newswire digital newsletter.